Milestone Scientific Inc.
MLSS · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.18 | 0.34 | 2.22 | -0.24 |
| FCF Yield | 0.00% | -3.39% | -1.32% | -1.98% |
| EV / EBITDA | -33.30 | -36.30 | -38.11 | -36.69 |
| Quality | ||||
| ROIC | -31.49% | -33.54% | -41.79% | -33.04% |
| Gross Margin | 0.00% | 69.62% | 73.80% | 75.05% |
| Cash Conversion Ratio | 1.19 | 0.51 | 0.74 | 0.67 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.08% | -3.04% | -0.34% | -0.67% |
| Free Cash Flow Growth | 0.00% | -75.45% | 33.46% | -56.62% |
| Safety | ||||
| Net Debt / EBITDA | 0.26 | 0.13 | 0.99 | 1.45 |
| Interest Coverage | 58.21 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.18 | 0.14 | 0.14 |
| Cash Conversion Cycle | 0.00 | 274.23 | 365.97 | 503.41 |